TECAR Therapy and Chronic Low Back Pain
Effect of TECAR Therapy on Patients With Chronic Low Back Pain: A Randomised Controlled Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
The goal of this clinical trial is to learn whether adding TECAR therapy to traditional physiotherapy is more effective than traditional physiotherapy alone for reducing pain and functional disability and improving physical performance in adults with chronic low back pain. The main questions it aims to answer are: Does adding TECAR therapy to traditional physiotherapy reduce pain intensity compared with traditional physiotherapy alone? Does adding TECAR therapy to traditional physiotherapy reduce functional disability? Does adding TECAR therapy improve core muscle endurance, back proprioception, back range of motion, and functional exercise capacity? Participants will: Receive 12 treatment sessions of either traditional physiotherapy with TECAR therapy or traditional physiotherapy alone. Have their pain intensity and functional disability assessed before and after treatment. Have their core muscle endurance, back proprioception, back range of motion, and functional exercise capacity assessed before and after treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 9, 2026
CompletedFirst Posted
Study publicly available on registry
September 17, 2026
CompletedStudy Start
First participant enrolled
October 20, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
August 20, 2027
Study Completion
Last participant's last visit for all outcomes
August 20, 2027
September 17, 2026
September 1, 2026
10 months
September 9, 2026
September 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pain Intensity Measured Using the Visual Analogue Scale (VAS)
Low back pain will be measured using the visual analogue scale (VAS) before and after the treatment. VAS is a scale ranging from 0 to 10 where 0 indicates no pain and 10 indicates severe pain.
Baseline, after 1 week and after 12 weeks
Pain threshold measured using the pressure algometer.
Pain threshold will be measured before and after treatment using a pressure algometer.
Baseline, 1 week and after 12 weeks
Secondary Outcomes (6)
Back range of motion measured using BROM device.
Baseline, 1 week and after 12 weeks
Functional disability measured using the Oswestry Disability Index
Baseline, 1 week and after 12 weeks
Quality of Life Measured Using the Short Form-36 Health Survey (SF-36)
Baseline, 1 week and after 12 weeks
Core Muscle Endurance Measured Using the McGill Core Endurance Test
Baseline, 1 week and after 12 weeks
Back Proprioception Measured Using the Back Range of Motion (BROM) Device
Baseline, 1 week and after 12 weeks
- +1 more secondary outcomes
Study Arms (2)
Control Group
SHAM COMPARATORTECAR Group
ACTIVE COMPARATORInterventions
Apply sham TECAR and physical therapy programmes, including core training exercises, myofascial release, and mobilisation exercises for three sessions per week for four weeks.
In addition to the programme given in the control group, the TECAR group, therapy was delivered using the TECAR device in resistive mode with a frequency of 500 kHz. A flexible, self-adhesive return electrode (10 cm × 18 cm) was placed on the abdomen as a reference electrode. The power output was gradually increased from approximately 30% to 60% of the device's maximum output (100 W), with adjustments based on patient-reported thermal feedback to ensure a consistent perception of mild to moderate warmth. Each quadrant of the lumbar region was treated for approximately 5 min, to 20 min per session
Eligibility Criteria
You may qualify if:
- localised pain between the 12th rib and the gluteal fold
- low back pain for more than three months
You may not qualify if:
- neuropathic pain extending along the lower limb
- previous spine surgery
- history of spine trauma or fracture,
- implanted pacemakers.
- pregnancy
- cancer
- systemic musculoskeletal diseases,
- neurodegenerative diseases.
- epilepsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
- Human TECAR, Jeddah, Saudi Arabiacollaborator
- Batterjee Medical Collegecollaborator
Study Sites (1)
Batterjee Medical college
Jeddah, 21442, Saudi Arabia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 9, 2026
First Posted
September 17, 2026
Study Start (Estimated)
October 20, 2026
Primary Completion (Estimated)
August 20, 2027
Study Completion (Estimated)
August 20, 2027
Last Updated
September 17, 2026
Record last verified: 2026-09